Oruka Therapeutics, Inc.
USD57.20
+1.97 (+3.57%)
CEO
Lawrence Otto Klein
IPO Date
1997-08-08
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$55.43
Prev. Close
$55.23
Day Low
$54.53
Day High
$58.48
52W Low
$10.77
52W High
$91.00
Market Cap
$2.14B
Volume
0.83M
| 11,904 |
| $7.80 |
| 22 May 2026 | Dambkowski Carl | director | M-Exempt | Acquired | 11,667 | $11.77 |
| 22 May 2026 | Dambkowski Carl | director | S-Sale | Disposed | 38,318 | $58.43 |
| 22 May 2026 | Dambkowski Carl | director | S-Sale | Disposed | 53,447 | $59.10 |
| 22 May 2026 | Dambkowski Carl | director | S-Sale | Disposed | 13,235 | $59.97 |
| 22 May 2026 | Dambkowski Carl | director | M-Exempt | Disposed | 38,689 | $6.84 |
| 22 May 2026 | Dambkowski Carl | director | M-Exempt | Disposed | 11,904 | $7.80 |
| 22 May 2026 | Dambkowski Carl | director | M-Exempt | Disposed | 11,667 | $11.77 |
| 18 May 2026 | Agarwal Arjun | Senior Vice President, Finance | M-Exempt | Acquired | 2,000 | $12.50 |